Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment, Expert Opinion on Therapeutic Targets, November 2014, Informa Healthcare,
DOI: 10.1517/14728222.2014.983078.
You can read the full text:
Contributors
The following have contributed to this page
